The Penetration of GLP-1 Weight Loss Drugs Declines for the Second Consecutive Month but Analysts Say This Is a Blip

After reaching a cyclical peak of around 5 percent in November 2023, the penetration of GLP-1 drugs in the US has declined to 4.2 percent.

Related Keywords

France ,Denmark ,North Carolina ,United States ,Carl Quintanilla ,Novo Nordisk Wegovy ,Eli Lilly ,Twitter ,Facebook ,Jp Morgan ,Novo Nordisk ,Company Zepbound ,Glucose Dependent Insulinotropic Polypeptide ,Marty Chargin ,Squawk Box ,